Lirio | Dec 16, 2024 | Behavioral Science, Blog, Closing Gaps in Care, Condition Management, Consumer Acquisition & Engagement, Consumer Satisfaction & Loyalty, Digital Health, News
The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
Sarah Deedat | Nov 20, 2024 | Behavioral Science, Blog, News
The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
Amy Bucher, Ph.D. | Oct 29, 2024 | Behavioral Science, Blog, Digital Health, Health Equity
Furniture and clothing are two obvious examples of why a “one-size-fits-all” design approach rarely works. But perhaps the best example is healthcare, where every patient or member has their own conditions and emotions. That’s why designing for health equity is...
Marten den Haring, Ph.D., MSc | Oct 8, 2024 | Artificial Intelligence, Behavioral Science, Blog, Digital Health
Patients checking their symptoms.Payers answering questions about plan coverage.Providers prompting patients to complete intake forms via automated reminder. AI chatbots in healthcare offer up a lot of answers. But, they also beg a lot of questions — namely around...
Amy Bucher, Ph.D. | Sep 12, 2024 | Artificial Intelligence, Behavioral Science, Blog, News
One of the most exciting opportunities we have at Lirio is to co-develop with our client partners. But academic literature doesn’t always deliver the insights we need to design and develop effective interventions, such as in the case of emerging medical innovations...
E. Susanne Blazek, Ph.D. | May 18, 2023 | Behavioral Science, Blog
In 2023, return on investment and clinical validation of a technology’s platform will be greatest indicators of a digital health company’s success (GSR Ventures, 2023). Recent efforts to examine clinical robustness in digital health companies find that many have in...
